These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12395362)

  • 1. Beta-adrenergic stimulation modulates the sodium current block by propafenone in rat ventricular myocardium.
    Maier SK; Kirstein M
    J Electrocardiol; 2002 Oct; 35(4):343-9. PubMed ID: 12395362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esmolol inhibits Na+ current in rat ventricular myocytes.
    Deng CY; Lin SG; Zhang WC; Kuang SJ; Qian WM; Wu SL; Shan ZX; Yang M; Yu XY
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):697-702. PubMed ID: 17235414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels.
    Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
    Eur J Pharmacol; 2013 Dec; 721(1-3):237-48. PubMed ID: 24070813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of drug-induced blockade of Na+ currents: interaction of antiarrhythmic compounds with DPI-modified single cardiac Na+ channels.
    Kohlhardt M; Fichtner H; Fröbe U; Herzig JW
    Circ Res; 1989 May; 64(5):867-81. PubMed ID: 2539922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine.
    Pugsley MK; Walker MJ; Saint DA
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):60-5. PubMed ID: 15730436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propafenone inhibition of human atrial myocyte repolarizing currents.
    Gross GJ; Castle NA
    J Mol Cell Cardiol; 1998 Apr; 30(4):783-93. PubMed ID: 9602427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
    Zaza A; Malfatto G; Schwartz PJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):336-43. PubMed ID: 8169840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation.
    Volders PG; Stengl M; van Opstal JM; Gerlach U; Spätjens RL; Beekman JD; Sipido KR; Vos MA
    Circulation; 2003 Jun; 107(21):2753-60. PubMed ID: 12756150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone.
    Kohlhardt M; Fichtner H
    J Membr Biol; 1988 May; 102(2):105-19. PubMed ID: 2458471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative modelling of interaction of propafenone with sodium channels in cardiac cells.
    Pásek M; Simurda J
    Med Biol Eng Comput; 2004 Mar; 42(2):151-7. PubMed ID: 15125143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The negative inotropic effect of esmolol on isolated cardiac muscle.
    Arlock P; Wohlfart B; Sjöberg T; Steen S
    Scand Cardiovasc J; 2005 Sep; 39(4):250-4. PubMed ID: 16118074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use dependent depression of fast sodium current in heart muscle by the new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015).
    Nilius B; Benndorf K; Schüttler K; Boldt W
    Pharmazie; 1985 Dec; 40(12):852-4. PubMed ID: 2419929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers as antiarrhythmic agents.
    Zicha S; Tsuji Y; Shiroshita-Takeshita A; Nattel S
    Handb Exp Pharmacol; 2006; (171):235-66. PubMed ID: 16610347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
    Greenberg S; Cantor E; Paul J
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential analysis of frequency-dependent effects of antiarrhythmic drugs: importance of the saturation behavior of frequency-dependent sodium-channel blockade.
    Weirich J; Hohnloser S; Antoni H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S8-16. PubMed ID: 1279314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action.
    Faber TS; Camm AJ
    Eur J Clin Pharmacol; 1996; 51(3-4):199-208. PubMed ID: 9010685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
    Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of diprafenone stereoenantiomers on cardiac Na+ channels.
    Kohlhardt M; Fichtner H
    Eur J Pharmacol; 1988 Oct; 156(1):55-62. PubMed ID: 2850211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient outward current inhibition by propafenone and 5-hydroxypropafenone in cultured neonatal rat ventricular myocytes.
    Cahill SA; Kirshenbaum LA; Gross GJ
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):460-7. PubMed ID: 11486250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of Vmax block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscle.
    Kohlhardt M; Seifert C
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):235-44. PubMed ID: 2414674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.